Dynamic Changes of the Bone Marrow Niche: Mesenchymal Stromal Cells and Their Progeny During Aging and Leukemia
暂无分享,去创建一个
[1] V. Beneš,et al. Single-cell proteo-genomic reference maps of the hematopoietic system enable the purification and massive profiling of precisely defined cell states , 2021, Nature Immunology.
[2] J. Dick,et al. "Human, mouse and dog bone marrow show similar mesenchymal stromal cells within a distinctive microenvironment". , 2021, Experimental hematology.
[3] S. Cairo,et al. Targeting mesenchymal stromal cells plasticity to reroute acute myeloid leukemia course. , 2021, Blood.
[4] E. Morii,et al. Identification of CXCL12‐abundant reticular cells in human adult bone marrow , 2021, British journal of haematology.
[5] Xiaoxiao Zhou,et al. CircRNA hsa_circ_0006215 promotes osteogenic differentiation of BMSCs and enhances osteogenesis–angiogenesis coupling by competitively binding to miR-942-5p and regulating RUNX2 and VEGF , 2021, Aging.
[6] Jiong Cai,et al. Non-Coding RNAs Steering the Senescence-Related Progress, Properties, and Application of Mesenchymal Stem Cells , 2021, Frontiers in Cell and Developmental Biology.
[7] R. Harman,et al. Translational Animal Models Provide Insight Into Mesenchymal Stromal Cell (MSC) Secretome Therapy , 2021, Frontiers in Cell and Developmental Biology.
[8] Jiao Li,et al. The elevated level of IL-1α in the bone marrow of aged mice leads to MSC senescence partly by down-regulating Bmi-1 , 2021, Experimental Gerontology.
[9] I. Dolgalev,et al. Connecting the Dots: Resolving the Bone Marrow Niche Heterogeneity , 2021, Frontiers in Cell and Developmental Biology.
[10] W. Shi,et al. RhoA/Rock activation represents a new mechanism for inactivating Wnt/β-catenin signaling in the aging-associated bone loss , 2021, Cell Regeneration.
[11] T. Schroeder,et al. Symmetric and asymmetric activation of hematopoietic stem cells , 2021, Current opinion in hematology.
[12] K. Lyons,et al. Loss of KDM4B exacerbates bone-fat imbalance and mesenchymal stromal cell exhaustion in skeletal aging. , 2021, Cell stem cell.
[13] M. Shimaoka,et al. Remodeling of Bone Marrow Niches and Roles of Exosomes in Leukemia , 2021, International journal of molecular sciences.
[14] Pengfei Qin,et al. Integrated decoding hematopoiesis and leukemogenesis using single-cell sequencing and its medical implication , 2021, Cell discovery.
[15] G. Mufti,et al. Ectopic humanized mesenchymal niche in mice enables robust engraftment of myelodysplastic stem cells. , 2020, Blood cancer discovery.
[16] Jeronimo Conceição Ruiz,et al. Microfluidics and organ-on-a-chip technologies: A systematic review of the methods used to mimic bone marrow , 2020, PloS one.
[17] P. Boor,et al. Heterogeneous bone-marrow stromal progenitors drive myelofibrosis via a druggable alarmin axis , 2020, Cell stem cell.
[18] Ying-ai Shi,et al. Sirt3 Attenuates Oxidative Stress Damage and Rescues Cellular Senescence in Rat Bone Marrow Mesenchymal Stem Cells by Targeting Superoxide Dismutase 2 , 2020, Frontiers in Cell and Developmental Biology.
[19] Katayoun Farrahi,et al. Transfer learning efficiently maps bone marrow cell types from mouse to human using single-cell RNA sequencing , 2020, Communications Biology.
[20] K. Xia,et al. Autophagy receptor OPTN (optineurin) regulates mesenchymal stem cell fate and bone-fat balance during aging by clearing FABP3 , 2020, Autophagy.
[21] F. Karadeniz,et al. Effect of Quercetin 3-O-β-D-Galactopyranoside on the Adipogenic and Osteoblastogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stromal Cells , 2020, International journal of molecular sciences.
[22] M. Boldin,et al. microRNA‐146a controls age‐related bone loss , 2020, Aging cell.
[23] Xiaoting Liang,et al. Senescent mesenchymal stem/stromal cells and restoring their cellular functions , 2020, World journal of stem cells.
[24] Y. Fujiwara,et al. Osteocyte RANKL is required for cortical bone loss with age and is induced by senescence , 2020, JCI insight.
[25] L. Liggett,et al. Unraveling Hematopoiesis through the Lens of Genomics , 2020, Cell.
[26] C. Nerlov,et al. Micro-environmental sensing by bone marrow stroma identifies IL-6 and TGFβ1 as regulators of hematopoietic ageing , 2020, Nature Communications.
[27] Xiaolong Liu,et al. Mesenchymal stromal cell therapies: immunomodulatory properties and clinical progress , 2020, Stem Cell Research & Therapy.
[28] Li Li,et al. Celastrol regulates bone marrow mesenchymal stem cell fate and bone-fat balance in osteoporosis and skeletal aging by inducing PGC-1α signaling , 2020, Aging.
[29] F. Vizoso,et al. Functional heterogeneity of mesenchymal stem cells from natural niches to culture conditions: implications for further clinical uses , 2020, Cellular and Molecular Life Sciences.
[30] B. Bisikirska,et al. Lipocalin-2 counteracts metabolic dysregulation in obesity and diabetes , 2020, The Journal of experimental medicine.
[31] J. Karp,et al. Shattering barriers toward clinically meaningful MSC therapies , 2020, Science Advances.
[32] O. Ornatsky,et al. Human Aging Alters the Spatial Organization between CD34+ Hematopoietic Cells and Adipocytes in Bone Marrow , 2020, Stem cell reports.
[33] Mingyao Li,et al. Single cell transcriptomics identifies a unique adipose lineage cell population that regulates bone marrow environment , 2020, eLife.
[34] M. Schiller,et al. Single-cell RNA sequencing deconvolutes the in vivo heterogeneity of human bone marrow-derived mesenchymal stem cells , 2020, bioRxiv.
[35] Yan Zhang,et al. Indian Hedgehog regulates senescence in bone marrow-derived mesenchymal stem cell through modulation of ROS/mTOR/4EBP1, p70S6K1/2 pathway , 2020, Aging.
[36] Byung-Kyu Suh,et al. Bone morbidity in pediatric acute lymphoblastic leukemia , 2020, Annals of pediatric endocrinology & metabolism.
[37] J. Gribben,et al. Bone marrow niches in haematological malignancies , 2020, Nature Reviews Cancer.
[38] Z. Estrov,et al. A phase 1/2 study of ruxolitinib and decitabine in patients with post-myeloproliferative neoplasm acute myeloid leukemia , 2020, Leukemia.
[39] J. Ankrum,et al. Editorial: Safety, Efficacy and Mechanisms of Action of Mesenchymal Stem Cell Therapies , 2020, Frontiers in Immunology.
[40] A. Martín-Montalvo,et al. Therapeutic Potential of Mesenchymal Stem Cells for Cancer Therapy , 2020, Frontiers in Bioengineering and Biotechnology.
[41] D. Vetrie,et al. The leukaemia stem cell: similarities, differences and clinical prospects in CML and AML , 2020, Nature Reviews Cancer.
[42] S. Kousteni,et al. Mapping and targeting of the leukemic microenvironment , 2019, The Journal of experimental medicine.
[43] B. Ebert,et al. Clonal Hematopoiesis as a Model for Premalignant Changes During Aging. , 2019, Experimental hematology.
[44] T. Schinke,et al. Chemokines in Physiological and Pathological Bone Remodeling , 2019, Front. Immunol..
[45] M. Longaker,et al. A Revised Perspective of Skeletal Stem Cell Biology , 2019, Front. Cell Dev. Biol..
[46] C. López-Otín,et al. Remodeling of Bone Marrow Hematopoietic Stem Cell Niches Promotes Myeloid Cell Expansion during Premature or Physiological Aging , 2019, Cell stem cell.
[47] R. Farahzadi,et al. Mesenchymal stem cells in acute myeloid leukemia: a focus on mechanisms involved and therapeutic concepts , 2019, Blood research.
[48] Patrick M. Helbling,et al. Global transcriptomic profiling of the bone marrow stromal microenvironment during postnatal development, aging and inflammation , 2019, bioRxiv.
[49] A. Iwama,et al. Bmi1 restricts the adipogenic differentiation of bone marrow stromal cells to maintain the integrity of the hematopoietic stem cell niche. , 2019, Experimental hematology.
[50] Patrick M. Helbling,et al. Combined single-cell and spatial transcriptomics reveals the molecular, cellular and spatial bone marrow niche organization , 2019, Nature Cell Biology.
[51] Anjali P. Kusumbe,et al. Angiocrine signals regulate quiescence and therapy resistance in bone metastasis , 2019, JCI insight.
[52] M. Le Bousse-Kerdilès,et al. Mesenchymal stromal cells confer chemoresistance to myeloid leukemia blasts through Side Population functionality and ABC transporter activation , 2019, Haematologica.
[53] Frédérick A. Mallette,et al. mTOR as a central regulator of lifespan and aging , 2019, F1000Research.
[54] Samuel L. Wolock,et al. Mapping Distinct Bone Marrow Niche Populations and Their Differentiation Paths. , 2019, Cell reports.
[55] Monika S. Kowalczyk,et al. A Cellular Taxonomy of the Bone Marrow Stroma in Homeostasis and Leukemia , 2019, Cell.
[56] D. Hedley,et al. Mobilization of Leukemic Cells Using Plerixafor as Part of a Myeloablative Preparative Regimen for Patients with Acute Myelogenous Leukemia Undergoing Allografting: Assessment of Safety and Tolerability. , 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[57] H. Ouyang,et al. Single-Cell Profiles and Clinically Useful Properties of Human Mesenchymal Stem Cells of Adipose and Bone Marrow Origin , 2019, The American journal of sports medicine.
[58] Michael R. Elliott,et al. Aged marrow macrophages expand platelet-biased hematopoietic stem cells via Interleukin1B. , 2019, JCI insight.
[59] Xiaoting Liang,et al. FGF21 Mediates Mesenchymal Stem Cell Senescence via Regulation of Mitochondrial Dynamics , 2019, Oxidative medicine and cellular longevity.
[60] R. Satija,et al. The bone marrow microenvironment at single-cell resolution , 2019, Nature.
[61] Avi Ma’ayan,et al. Engineering a haematopoietic stem cell niche by revitalizing mesenchymal stromal cells , 2019, Nature Cell Biology.
[62] P. Frenette,et al. Haematopoietic stem cell activity and interactions with the niche , 2019, Nature Reviews Molecular Cell Biology.
[63] A. Barrett,et al. Human Wharton's Jelly Mesenchymal Stem Cells Show Unique Gene Expression Compared with Bone Marrow Mesenchymal Stem Cells Using Single-Cell RNA-Sequencing. , 2019, Stem cells and development.
[64] H. Koo,et al. Mesenchymal stem cells in suppression or progression of hematologic malignancy: current status and challenges , 2019, Leukemia.
[65] B. Ebert,et al. Rps14, Csnk1a1 and miRNA145/miRNA146a deficiency cooperate in the clinical phenotype and activation of the innate immune system in the 5q- syndrome , 2019, Leukemia.
[66] Yingdong Zhao,et al. Single cell sequencing reveals gene expression signatures associated with bone marrow stromal cell subpopulations and time in culture , 2019, Journal of Translational Medicine.
[67] Mi Yang,et al. Long noncoding RNA Bmncr regulates mesenchymal stem cell fate during skeletal aging , 2018, The Journal of clinical investigation.
[68] J. Jing,et al. BMP-IHH-mediated interplay between mesenchymal stem cells and osteoclasts supports calvarial bone homeostasis and repair , 2018, Bone Research.
[69] C. Piccinato,et al. Individual response to mTOR inhibition in delaying replicative senescence of mesenchymal stromal cells , 2018, bioRxiv.
[70] Marc N. Wein,et al. Regulation of Bone Remodeling by Parathyroid Hormone. , 2018, Cold Spring Harbor perspectives in medicine.
[71] L. Mei,et al. YAP promotes osteogenesis and suppresses adipogenic differentiation by regulating β-catenin signaling , 2018, Bone Research.
[72] U. Platzbecker,et al. Associations of myeloid hematological diseases of the elderly with osteoporosis: A longitudinal analysis of routine health care data. , 2018, Leukemia research.
[73] J. Scandura,et al. Phase I trial of plerixafor combined with decitabine in newly diagnosed older patients with acute myeloid leukemia , 2018, Haematologica.
[74] M. Schäfers,et al. Autoinhibitory regulation of S100A8/S100A9 alarmin activity locally restricts sterile inflammation , 2018, The Journal of clinical investigation.
[75] P. Frenette,et al. Niches for Hematopoietic Stem Cells and Their Progeny. , 2018, Immunity.
[76] Albert A. Rizvanov,et al. Application of Mesenchymal Stem Cells for Therapeutic Agent Delivery in Anti-tumor Treatment , 2018, Front. Pharmacol..
[77] A. Zimran,et al. Bone loss and hematological malignancies in adults: a pilot study , 2018, Supportive Care in Cancer.
[78] P. Frenette,et al. Adrenergic nerve degeneration in bone marrow drives aging of the hematopoietic stem cell niche , 2018, Nature Medicine.
[79] M. Carroll,et al. Dexamethasone in hyperleukocytic acute myeloid leukemia , 2018, Haematologica.
[80] T. Barbui,et al. The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion , 2018, Blood Cancer Journal.
[81] Catriona McLean,et al. Inhibition of Endosteal Vascular Niche Remodeling Rescues Hematopoietic Stem Cell Loss in AML , 2018, Cell stem cell.
[82] O. Ilhan,et al. DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemia. , 2017, Leukemia research.
[83] R. Cancedda,et al. LCN2 overexpression in bone enhances the hematopoietic compartment via modulation of the bone marrow microenvironment , 2017, Journal of cellular physiology.
[84] Michael G. Kharas,et al. Epigenetically Aberrant Stroma in MDS Propagates Disease via Wnt/β-Catenin Activation. , 2017, Cancer research.
[85] S. Soneji,et al. Human Primary Bone Marrow Mesenchymal Stromal Cells and Their in vitro Progenies Display Distinct Transcriptional Profile Signatures , 2017, Scientific Reports.
[86] Hartmut Geiger,et al. HSC Niche Biology and HSC Expansion Ex Vivo. , 2017, Trends in molecular medicine.
[87] E. Hsiao,et al. Sirtuin‐3 Promotes Adipogenesis, Osteoclastogenesis, and Bone Loss in Aging Male Mice , 2017, Endocrinology.
[88] C. Chen,et al. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion , 2017, Leukemia.
[89] Jennifer M. Miller,et al. Interleukin-6 levels predict event-free survival in pediatric AML and suggest a mechanism of chemotherapy resistance. , 2017, Blood advances.
[90] Je-Yoel Cho,et al. Fibroblast growth factor 2 supports osteoblastic niche cells during hematopoietic homeostasis recovery after bone marrow suppression , 2017, Cell Communication and Signaling.
[91] L. Calvi,et al. The Notch Ligand Jagged1 Regulates the Osteoblastic Lineage by Maintaining the Osteoprogenitor Pool , 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[92] M. L. Le Beau,et al. Inhibition of WNT signaling in the bone marrow niche prevents the development of MDS in the Apcdel/+ MDS mouse model. , 2017, Blood.
[93] Victor G. Puelles,et al. Gli1+ Mesenchymal Stromal Cells Are a Key Driver of Bone Marrow Fibrosis and an Important Cellular Therapeutic Target. , 2017, Cell stem cell.
[94] R. Baron,et al. Parathyroid Hormone Directs Bone Marrow Mesenchymal Cell Fate. , 2017, Cell metabolism.
[95] C. Rosen,et al. Bone-Fat Interaction. , 2017, Endocrinology and metabolism clinics of North America.
[96] J. Gribben,et al. Versatile humanized niche model enables study of normal and malignant human hematopoiesis , 2017, The Journal of clinical investigation.
[97] S. Goodman,et al. Decreased osteogenesis in mesenchymal stem cells derived from the aged mouse is associated with enhanced NF‐κB activity , 2017, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[98] Yulin Li,et al. Nampt Expression Decreases Age-Related Senescence in Rat Bone Marrow Mesenchymal Stem Cells by Targeting Sirt1 , 2017, PloS one.
[99] G. Blunn,et al. Parathyroid hormone 1-34 and skeletal anabolic action , 2017, Bone & joint research.
[100] E. Scott,et al. Extended time-lapse in vivo imaging of tibia bone marrow to visualize dynamic hematopoietic stem cell engraftment , 2016, Leukemia.
[101] B. Ebert,et al. The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia , 2016, Nature Reviews Cancer.
[102] R. Kanaar,et al. Mesenchymal Inflammation Drives Genotoxic Stress in Hematopoietic Stem Cells and Predicts Disease Evolution in Human Pre-leukemia. , 2016, Cell stem cell.
[103] D. Scadden,et al. Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironment , 2016, Nature.
[104] Yongchang Chen,et al. Exosomes derived from human mesenchymal stem cells promote gastric cancer cell growth and migration via the activation of the Akt pathway. , 2016, Molecular medicine reports.
[105] R. Oster,et al. Enhanced Hematopoietic Stem Cell Self‐Renewal‐Promoting Ability of Clonal Primary Mesenchymal Stromal/Stem cells Versus Their Osteogenic Progeny , 2016, Stem cells.
[106] D. Scadden,et al. Distinctive Mesenchymal-Parenchymal Cell Pairings Govern B Cell Differentiation in the Bone Marrow , 2016, Stem cell reports.
[107] O. MacDougald,et al. Marrow Adipose Tissue: Trimming the Fat , 2016, Trends in Endocrinology & Metabolism.
[108] Mario Cazzola,et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. , 2016, Blood.
[109] Ron-Patrick Cadeddu,et al. Functional inhibition of mesenchymal stromal cells in acute myeloid leukemia , 2016, Leukemia.
[110] X Zhang,et al. Fate decision of mesenchymal stem cells: adipocytes or osteoblasts? , 2016, Cell Death and Differentiation.
[111] Z. Gu,et al. Mesenchymal stem cell-derived exosomes facilitate nasopharyngeal carcinoma progression. , 2016, American journal of cancer research.
[112] Charles P. Lin,et al. Distinct Bone Marrow Blood Vessels Differentially Regulate Normal and Malignant Hematopoietic Stem and Progenitor Cells , 2015 .
[113] Fengyun Zhang,et al. Macrophage migration inhibitory factor confers resistance to senescence through CD74-dependent AMPK-FOXO3a signaling in mesenchymal stem cells , 2015, Stem Cell Research & Therapy.
[114] S. Leem,et al. Microenvironmental remodeling as a parameter and prognostic factor of heterogeneous leukemogenesis in acute myelogenous leukemia. , 2015, Cancer research.
[115] P. Bianco,et al. Skeletal stem cells , 2015, Development.
[116] Andrew F. Hill,et al. Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper , 2015, Journal of extracellular vesicles.
[117] C. Brochhausen-Delius,et al. Prostaglandin E2 , 2014, Der Pathologe.
[118] R. Yadak,et al. SMAD Signaling Regulates CXCL12 Expression in the Bone Marrow Niche, Affecting Homing and Mobilization of Hematopoietic Progenitors , 2014, Stem cells.
[119] S. Armstrong,et al. Acute myelogenous leukemia-induced sympathetic neuropathy promotes malignancy in an altered hematopoietic stem cell niche. , 2014, Cell stem cell.
[120] H. Okano,et al. Leptin receptor makes its mark on MSCs. , 2014, Cell stem cell.
[121] Y. Hayashi,et al. Parathyroid Hormone Enhances Hematopoietic Expansion Via Upregulation of Cadherin‐11 in Bone Marrow Mesenchymal Stromal Cells , 2014, Stem cells.
[122] D. Lai,et al. Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms , 2014, Nature.
[123] T. Enver,et al. Leukemia propagating cells rebuild an evolving niche in response to therapy. , 2014, Cancer cell.
[124] D. Bernlohr,et al. Lipocalin 2 Regulates Brown Fat Activation via a Nonadrenergic Activation Mechanism* , 2014, The Journal of Biological Chemistry.
[125] A. Trumpp,et al. Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unit. , 2014, Cell stem cell.
[126] R. Adams,et al. Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone , 2014, Nature.
[127] A. Jahanian-Najafabadi,et al. Lipocalin 2 decreases senescence of bone marrow-derived mesenchymal stem cells under sub-lethal doses of oxidative stress , 2014, Cell Stress and Chaperones.
[128] R. Rabadán,et al. Leukemogenesis Induced by an Activating β-catenin mutation in Osteoblasts , 2014, Nature.
[129] C. Paton,et al. Lipocalin‐2 increases fat oxidation in vitro and is correlated with energy expenditure in normal weight but not obese women , 2013, Obesity.
[130] A. Bergman,et al. Arteriolar niches maintain haematopoietic stem cell quiescence , 2013, Nature.
[131] T. Olson,et al. IGF‐1‐mediated osteoblastic niche expansion enhances long‐term hematopoietic stem cell engraftment after murine bone marrow transplantation , 2013, Stem cells.
[132] Greg Maguire,et al. Stem cell therapy without the cells , 2013, Communicative & integrative biology.
[133] E. Hsiao,et al. Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche. , 2013, Cell stem cell.
[134] I. Bruns,et al. Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells , 2013, Leukemia.
[135] C. Di Cresce,et al. Regional localization within the bone marrow influences the functional capacity of human HSCs. , 2013, Cell stem cell.
[136] I. Bruns,et al. PDGFRα and CD51 mark human Nestin+ sphere-forming mesenchymal stem cells capable of hematopoietic progenitor cell expansion , 2013, The Journal of experimental medicine.
[137] R. Zhao,et al. Exosomes from human adipose-derived mesenchymal stem cells promote migration through Wnt signaling pathway in a breast cancer cell model , 2013, Molecular and Cellular Biochemistry.
[138] H. Northoff,et al. Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells , 2013, BMC Medicine.
[139] A. Jahanian-Najafabadi,et al. Lipocalin-2-mediated upregulation of various antioxidants and growth factors protects bone marrow-derived mesenchymal stem cells against unfavorable microenvironments , 2013, Cell Stress and Chaperones.
[140] S. Rafii,et al. TGFβ restores hematopoietic homeostasis after myelosuppressive chemotherapy , 2013, The Journal of experimental medicine.
[141] Lev Silberstein,et al. Differential Stem and Progenitor Cell Trafficking by Prostaglandin E2 , 2013, Nature.
[142] R. Baron,et al. Myelopoiesis is regulated by osteocytes through Gsα-dependent signaling. , 2013, Blood.
[143] S. Morrison,et al. Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches , 2013, Nature.
[144] A. Korman,et al. BMS-936564/MDX-1338: A Fully Human Anti-CXCR4 Antibody Induces Apoptosis In Vitro and Shows Antitumor Activity In Vivo in Hematologic Malignancies , 2012, Clinical Cancer Research.
[145] L. Calvi,et al. PTH expands short-term murine hemopoietic stem cells through T cells. , 2012, Blood.
[146] P. Opolon,et al. CXCR4 inhibitors selectively eliminate CXCR4-expressing human acute myeloid leukemia cells in NOG mouse model , 2012, Cell Death and Disease.
[147] L. Xian,et al. Parathyroid hormone induces differentiation of mesenchymal stromal/stem cells by enhancing bone morphogenetic protein signaling , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[148] Marcos González,et al. Impaired expression of DICER, DROSHA, SBDS and some microRNAs in mesenchymal stromal cells from myelodysplastic syndrome patients , 2012, Haematologica.
[149] Je-Yoel Cho,et al. Differential regulation of CXCL5 by FGF2 in osteoblastic and endothelial niche cells supports hematopoietic stem cell migration. , 2012, Stem cells and development.
[150] F. Jakob,et al. Indian hedgehog gene transfer is a chondrogenic inducer of human mesenchymal stem cells , 2012, Arthritis Research & Therapy.
[151] P. Madeddu,et al. Bone marrow microenvironment: a newly recognized target for diabetes-induced cellular damage. , 2012, Endocrine, metabolic & immune disorders drug targets.
[152] L. Calvi,et al. Osteoblastic expansion induced by parathyroid hormone receptor signaling in murine osteocytes is not sufficient to increase hematopoietic stem cells. , 2012, Blood.
[153] Lei Ding,et al. Endothelial and perivascular cells maintain haematopoietic stem cells , 2011, Nature.
[154] K. Tian,et al. p38 MAPK Contributes to the Growth Inhibition of Leukemic Tumor Cells Mediated by Human Umbilical Cord Mesenchymal Stem Cells , 2011, Cellular Physiology and Biochemistry.
[155] Ben D. MacArthur,et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche , 2010, Nature.
[156] K. Lyons,et al. Wnt10b Deficiency Results in Age-Dependent Loss of Bone Mass and Progressive Reduction of Mesenchymal Progenitor Cells , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[157] Wendy S. Wright,et al. Lipocalin-2 Deficiency Impairs Thermogenesis and Potentiates Diet-Induced Insulin Resistance in Mice , 2010, Diabetes.
[158] Charles P. Lin,et al. Bone progenitor dysfunction induces myelodysplasia and secondary leukemia , 2010, Nature.
[159] A. Rustgi,et al. Identification of a bone marrow-derived mesenchymal progenitor cell subset that can contribute to the gastric epithelium , 2009, Laboratory Investigation.
[160] A. S. Bailey,et al. BMP4 regulates the hematopoietic stem cell niche. , 2009, Blood.
[161] R. O’Keefe,et al. In vivo prostaglandin E2 treatment alters the bone marrow microenvironment and preferentially expands short-term hematopoietic stem cells. , 2009, Blood.
[162] A. Miyawaki,et al. Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow , 2009, The Journal of experimental medicine.
[163] A. C. Yazici,et al. Human bone marrow mesenchymal cells express NG2: possible increase in discriminative ability of flow cytometry during mesenchymal stromal cell identification. , 2009, Cytotherapy.
[164] Gang Li,et al. Human mesenchymal stem cells (hMSCs) target osteosarcoma and promote its growth and pulmonary metastasis. , 2009, Cancer letters.
[165] J. Sampath,et al. Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation. , 2009, Blood.
[166] A. Kate Sasser,et al. Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression , 2009, PloS one.
[167] A. McMahon,et al. Osteoblastic regulation of B lymphopoiesis is mediated by Gsα-dependent signaling pathways , 2008, Proceedings of the National Academy of Sciences.
[168] Y. Shiozawa,et al. Hematopoietic Stem Cells Regulate Mesenchymal Stromal Cell Induction into Osteoblasts Thereby Participating in the Formation of the Stem Cell Niche , 2008, Stem cells.
[169] Yukio Nakamura,et al. Lipocalin 2‐mediated growth suppression is evident in human erythroid and monocyte/macrophage lineage cells , 2008, Journal of cellular physiology.
[170] Zhe Wang,et al. Effects of human bone marrow stromal cell line (HFCL) on the proliferation, differentiation and apoptosis of acute myeloid leukemia cell lines U937, HL-60 and HL-60/VCR , 2008, International journal of hematology.
[171] T. Suda,et al. Thrombopoietin/MPL signaling regulates hematopoietic stem cell quiescence and interaction with the osteoblastic niche. , 2007, Cell stem cell.
[172] Lina A. Thoren,et al. Critical role of thrombopoietin in maintaining adult quiescent hematopoietic stem cells. , 2007, Cell stem cell.
[173] Satoshi Tanaka,et al. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region , 2007, Nature Biotechnology.
[174] B. Sacchetti,et al. Self-Renewing Osteoprogenitors in Bone Marrow Sinusoids Can Organize a Hematopoietic Microenvironment , 2007, Cell.
[175] D. Banerjee,et al. The therapeutic potential of mesenchymal stem cells , 2007, Expert opinion on biological therapy.
[176] D. Scadden,et al. Therapeutic targeting of a stem cell niche , 2007, Nature Biotechnology.
[177] L. Calvi,et al. The interplay of osteogenesis and hematopoiesis , 2004, The Journal of cell biology.
[178] Keisuke Ito,et al. Tie2/Angiopoietin-1 Signaling Regulates Hematopoietic Stem Cell Quiescence in the Bone Marrow Niche , 2004, Cell.
[179] T. Jensen,et al. Regulation of Human Skeletal Stem Cells Differentiation by Dlk1/Pref‐1 , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[180] D. Scadden,et al. Osteoblastic cells regulate the haematopoietic stem cell niche , 2003, Nature.
[181] Haiyang Huang,et al. Identification of the haematopoietic stem cell niche and control of the niche size , 2003, Nature.
[182] F. Appelbaum,et al. Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5). , 2001, Experimental hematology.
[183] R. Baron,et al. Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone. , 2001, The Journal of clinical investigation.
[184] M. Pittenger,et al. Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.
[185] A. Cryer,et al. The differentiation of a potential mesenchymal stem cell population within ovine bone marrow. , 1994, Biochemical Society transactions.
[186] U. Trechsel. [The regulation of bone remodeling]. , 1986, Schweizerische medizinische Wochenschrift.
[187] D. Goltzman. The Aging Skeleton. , 2019, Advances in experimental medicine and biology.
[188] J. Esteve,et al. A phase I–II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia , 2018, Annals of Hematology.
[189] David W. Rowe,et al. Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche , 2009, Nature.
[190] Winfried Wiegraebe,et al. Detection of functional haematopoietic stem cell niche using real-time imaging , 2009, Nature.
[191] J. Sampath,et al. Prostaglandin E 2 enhances hematopoietic stem cell homing , survival , and proliferation , 2009 .
[192] R. O’Keefe,et al. In vivo prostaglandin E 2 treatment alters the bone marrow microenvironment and preferentially expands short-term hematopoietic stem cells , 2009 .
[193] 杉山 立樹. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches , 2007 .
[194] D. Prockop,et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.
[195] I. Wilmut. Differentiation potential. , 1999, Cloning.
[196] J. David. Macrophage migration. , 1968, Federation proceedings.
[197] P. Boccuni,et al. Transforming growth factor (cid:1) -induced cell cycle arrest of human hematopoietic cells requires p57KIP2 up-regulation , 2004 .